(NASDAQ: TECX) Tectonic Therapeutic's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.83%.
Tectonic Therapeutic's earnings in 2025 is -$58,667,000.On average, 3 Wall Street analysts forecast TECX's earnings for 2025 to be -$87,512,448, with the lowest TECX earnings forecast at -$105,126,226, and the highest TECX earnings forecast at -$74,316,586. On average, 3 Wall Street analysts forecast TECX's earnings for 2026 to be -$91,060,225, with the lowest TECX earnings forecast at -$130,707,563, and the highest TECX earnings forecast at -$56,577,702.
In 2027, TECX is forecast to generate -$126,039,436 in earnings, with the lowest earnings forecast at -$186,725,090 and the highest earnings forecast at -$65,353,782.